Reliability and validity of the K-force grip dynamometer in healthy subjects: do we need to assess it three times?

Introduction: Digital dynamometers to assess grip strength are becoming more common in research and clinical settings. The aim of the study was to assess validity and reliability of the K-force dynamometer compared to the Jamar dynamometer. We also aimed to assess differences over the course of three measurements. Methods: Twenty-seven healthy participants were included. Three trials with the K-force and Jamar dynamometers were completed. Testing order was randomised. Intraclass correlation coefficients (ICCs) with absolute agreement assessed reliability and validity. Standard error of the measurement (SEM) and minimal detectable change (MDC95) were calculated. Concurrent validity was assessed using Pearson's correlations and ICCs. Differences between the three repetitions were assessed using one-way repeated measures ANOVAs. Results: Both the K-force and the Jamar presented excellent intra-rater reliability with ICCs ranging from 0.96 to 0.97. The SEM ranged from 1.7 to 2 kg and the MDC from 4.7 to 5.7 kg for both dynamometers. The concurrent validity of the K-force was high (r ≥ 0.89). However, the K-force underestimated the grip strength by 4.5-8.5 kg. There was no change in grip strength with either dynamometer over the course of three trials. Conclusions: The K-force is reliable, but it underestimates grip strength by 4.5-8.5 kg compared to the Jamar dynamometer. K-force can be used to monitor progress over time but cannot be used to compare results against normative data. The use of a single measurement when assessing grip strength is sufficient when assessing healthy subjects.

Validity and Reliability of the Kinvent Handheld Dynamometer in the Athletic Shoulder Test.

CONTEXT: Long-lever shoulder strength tests may aid clinical decision-making regarding return to sport after a shoulder injury. The Athletic Shoulder Test (AST) was developed to measure force production in 3 positions of shoulder abduction (90°, 135°, and 180°) using force plates. However, handheld dynamometers (HHDs) are more portable, affordable, and may provide valid and reliable results which would increase the clinical utility of long-lever tests. HHDs vary in shape, design, and their capacity to report parameters such as rate of force production and require further investigation. The aim of this study was to examine the intrarater reliability of the Kinvent HHD and assess its validity against Kinvent force plates in the AST. Peak force (in kilograms), torque (in Newton meters), and normalized torque (in Newton meters per kilogram) were reported. DESIGN: Validity and reliability study. METHODS: Twenty-seven participants with no history of upper limb injury performed the test in a randomized order using the Kinvent HHD and force plates. Each condition was assessed 3 times, and peak force was recorded. Arm length was measured to calculate peak torque. Normalized peak torque was calculated by dividing torque by bodyweight (in kilograms). RESULTS: The Kinvent HHD is reliable when measuring force (intraclass correlation coefficient [ICC] ≥ .80), torque (ICC ≥ .84), and normalized torque (ICC ≥ .64) during the AST. The Kinvent HHD is also valid when compared with the Kinvent force plates for force (ICC ≥ .79; r ≥ .82), torque (ICC ≥ .82; r ≥ .76), and normalized torque (ICC ≥ .71; r ≥ .61). There were no statistically significant differences across the 3 trials on analyses of variance (P > .05). CONCLUSIONS: The Kinvent HHD is a reliable tool when used to measure force, torque, and normalized torque in the AST. Furthermore, given the lack of significant difference between trials, clinicians can use one test to accurately report relative peak force/torque/normalized torque rather than average 3 separate trials. Finally, the Kinvent HHD is valid when compared with Kinvent force plates.

Neuropathic Pain in Hand Osteoarthritis: A Cross-Sectional Study.

Symptomatic hand osteoarthritis (OA) is a severely debilitating condition. Neuropathic pain (NP) has been shown to be a factor affecting pain severity, hand function, psychological wellbeing, body schema, and the number of pain medications in people with OA of other joints. The aim of this study was to assess the prevalence of NP in symptomatic hand OA and assess its association with pain, hand function, measures of psychological wellbeing, sleep, body schema disturbances, and number of pain medications. Participants with symptomatic hand OA diagnosed through the American College of Rheumatology criteria, were recruited and completed a series of online questionnaires. These included the Douleur Neuropathique 4 interview (DN4-interview), Short Form Brief Pain Inventory (SF-BPI), Neglect-like Symptoms questionnaire, Functional Index of Hand Osteoarthritis (FIHOA), Centre for Epidemiologic Studies Depression Scale (CES-D), Pain Catastrophising Scale (PCS), and the Pittsburgh Sleep Quality Index (PSQI). Logistic regression with age, body mass index, and sex as covariates were utilised to assess differences between participants with and without NP as identified through the DN4-interview. Correlation analysis assessed the relationship between pain intensity, body schema alterations, and number of pain medications. A total of 121 participants were included in the present study. Forty-two percent of participants presented with NP. Participants with NP reported higher levels of worst pain (OR: 10.2 95% CI: 2.2 to 48.5; p = 0.007). Worst pain intensity correlated with the number of pain medications (rho = 0.2; p = 0.04), and neglect-like symptoms (rho = 0.4; p < 0.0001). No difference between phenotypes was shown for catastrophising, function, depression, neglect-like symptoms, pain interference, or sleep. A large proportion of people with symptomatic hand OA present with NP. This phenotype is characterised by greater levels of pain intensity. Pain intensity is associated with number of pain relief medications and body schema alteration. Psychological factors, hand function, and sleep do not appear to be affected by the presence of NP.

The Prevalence, Characteristics and Impact of Chronic Pain in People With Muscular Dystrophies: A Systematic Review and Meta-Analysis.

Chronic pain is a frequent, yet under-recognized and under-assessed problem in people with muscular dystrophies (MDs). Knowledge of the prevalence and characteristics of chronic pain, and its impact on function and quality of life is limited and lacks systematic exploration. This article aims to systematically review and synthesize existing literature that addresses chronic pain prevalence, characteristics and impact in people with different types of MDs. The present meta-analysis showed that the estimated prevalence of chronic pain in MDs is high and appears to be similar across different diagnostic groups: 68% (95% CI: 52%-82%) in FSHD, 65% (95% CI: 51%-77%) in DM, 62% (95% CI: 50%-73%) in BMD/DMD, and 60% (95% CI: 48%-73%) in LGMD, although it should be noted that heterogeneity was high in some diagnostic groups. On average, people with FSHD and DM present with moderate pain intensity. The lumbar spine, shoulders and legs are the most frequent sites of chronic pain among people with FSHD, DM, BMD/DMD, and LGMD, with little variation. Diffuse pain across multiple body sites was reported by a notable proportion of these individuals. Chronic pain has a negative impact on daily life activities in people with MDs, and may also contribute to decreased quality of life. The protocol for this review has been published on PROSPERO (CRD42020168096). PERSPECTIVES: This is the first systematic review and meta-analysis exploring the prevalence, and nature and impact of chronic pain in people with MDs. The present study demonstrates how common chronic pain is across various MD populations and highlights the need for better recognition and understanding of the nature and impact of pain from health professionals.